Skip to main content
Top
Published in: Journal of General Internal Medicine 5/2020

01-05-2020 | Blood Pressure Measurement | Concise Research Report

Flipping the Visit: Impact of Blood Pressure Remeasurement after the Visit

Authors: Jeffrey D. Kravetz, MD, Kara Cleveland, RN, Scott Beauregard, RN

Published in: Journal of General Internal Medicine | Issue 5/2020

Login to get access

Excerpt

Hypertension is one of the most common conditions managed in primary care and is a major risk factor for cardiovascular morbidity and mortality. With the release of the 2017 ACC/AHA hypertension guidelines with new thresholds for diagnosis, the age-standardized prevalence of hypertension increased from 29% (JNC7 guidelines) to 45.5% in 2015–2016.1, 2 While hypertension remains one of the most impactful conditions primary care physicians manage, overtreatment can adversely affect patients. In a cohort of over 300,000 elderly patients newly treated for hypertension, there was a 43% increased risk of hip fracture occurring within 45 days following treatment initiation.3 In addition, low daytime systolic BP (< 128 mmHg) has been shown to be independently associated with greater progression of cognitive decline in a cohort of elderly patients with baseline cognitive impairment.4 Accurate assessment of BP is imperative to avoid overtreatment, especially in the elderly population. It is well known that many factors affect BP measurement, including talking, smoking, mental stress, and measurement in the inappropriate position and over clothing.5 Many of these factors exist just prior to an office visit and can be eliminated if the BP is assessed following the visit. We undertook this quality improvement initiative to determine the impact of BP reassessment after a clinic visit in a select population of male veterans. …
Literature
1.
go back to reference Whelton PK, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018; 71:e13–e115.PubMed Whelton PK, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018; 71:e13–e115.PubMed
3.
go back to reference Butt DA, et al. The risk of hip fracture after initiating antihypertensive drugs in the elderly. Arch Intern Med. 2012;172(22):1739–1744.CrossRef Butt DA, et al. The risk of hip fracture after initiating antihypertensive drugs in the elderly. Arch Intern Med. 2012;172(22):1739–1744.CrossRef
4.
go back to reference Mossello E, et al. Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs. JAMA Intern Me. 2015;175(4):578–585.CrossRef Mossello E, et al. Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs. JAMA Intern Me. 2015;175(4):578–585.CrossRef
5.
go back to reference Handler J. The importance of accurate blood pressure measurement. Perm J. 2009;13:51–54.CrossRef Handler J. The importance of accurate blood pressure measurement. Perm J. 2009;13:51–54.CrossRef
6.
go back to reference Bos MJ, Buis S. Thirty-minute office blood pressure monitoring in primary care. Ann Fam Med. 2017;15:120–123.CrossRef Bos MJ, Buis S. Thirty-minute office blood pressure monitoring in primary care. Ann Fam Med. 2017;15:120–123.CrossRef
Metadata
Title
Flipping the Visit: Impact of Blood Pressure Remeasurement after the Visit
Authors
Jeffrey D. Kravetz, MD
Kara Cleveland, RN
Scott Beauregard, RN
Publication date
01-05-2020
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 5/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05359-y

Other articles of this Issue 5/2020

Journal of General Internal Medicine 5/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.